Advisory Research’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-873,987
Closed -$34.4M 363
2018
Q3
$34.4M Buy
873,987
+95,426
+12% +$4.3M 0.56% 48
2018
Q2
$38.3M Buy
778,561
+108,211
+16% +$6.14M 0.61% 37
2018
Q1
$40.1M Buy
670,350
+28,807
+4% +$1.92M 0.72% 41
2017
Q4
$50.5M Sell
641,543
-89,005
-12% -$7.18M 0.84% 35
2017
Q3
$61.4M Sell
730,548
-26,801
-4% -$1.9M 0.98% 27
2017
Q2
$49.5M Buy
757,349
+108,547
+17% +$7.38M 0.78% 33
2017
Q1
$47.1M Buy
648,802
+218,304
+51% +$14.3M 0.69% 40
2016
Q4
$25.2M Buy
+430,498
New +$22.7M 0.38% 73

Other funds holding ADNT

Advisory Research's ADNT Position: Q4 2018 in Review

Advisory Research sold out of Adient (ADNT) in Q4 2018, closing a stake of 873,987 shares — an estimated $34.4M sold.

Advisory Research first reported a position in ADNT in Q4 2016 and held it in 8 quarters. The position peaked at $61.4M in Q3 2017. 347 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.

  • Advisory Research reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
  • Advisory Research sold 873,987 Adient shares in Q4 2018, an estimated $34.4M.
  • Advisory Research first reported a position in Adient in Q4 2016 and held it in 8 quarters.
  • Advisory Research's Adient position peaked at $61.4M in Q3 2017.
  • 347 funds tracked by Wall St. Rank held Adient as of Q4 2018.

Based on Advisory Research's 13F filing for Q4 2018, filed 13 Feb 2019.